---
title: "Methylphenidate Hydrochloride Extended-Release Tablet Shortage: Supply Updates and Manufacturer Status"
summary: "A shortage of Methylphenidate Hydrochloride extended-release tablets, used in psychiatry, is ongoing due to active ingredient supply issues affecting several manufacturers."
category: "drug-shortages"
tags: ["drug-shortage","fda","medication","Methylphenidate","Tablet"]
location: "United States"
severity: "medium"
sourceUrl: "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
sourceAgency: "FDA"
publishedAt: 2026-02-11T14:39:20.000Z
---
# What's in Shortage

**Generic Name**: Methylphenidate Hydrochloride Tablet, Extended Release  
**Brand Names**: Concerta, Relexxii, Methylin ER  
**Dosage Form**: Tablet, Extended Release (various strengths including 10 mg, 18 mg, 20 mg, 27 mg, 36 mg, 45 mg, 54 mg, 63 mg, and 72 mg)  
**Therapeutic Category**: Psychiatry  
**Current Status**: Ongoing shortage  
**Initial Posting Date**: 07/26/2023  
**Last Updated**: 02/02/2026

# Which Manufacturers Are Affected

Availability varies significantly by manufacturer and dosage strength:

*   **Janssen Pharmaceuticals (Concerta)**: All strengths (18 mg, 27 mg, 36 mg, 54 mg) are currently **Available**.  
    *Contact: 800-526-7736*
*   **Teva Pharmaceuticals USA, Inc.**: Most strengths (27 mg, 36 mg, 54 mg) are **Available**; 18 mg is under **Limited Availability**.  
    *Contact: 800-545-8800*
*   **Vertical Pharmaceuticals, LLC (Relexxii)**: Mixed status. Several strengths (18 mg, 27 mg, 36 mg, 45 mg, 54 mg, 63 mg, 72 mg) are **Available**, while specific NDCs for 18 mg, 27 mg, 36 mg, and 54 mg are **Unavailable** with recovery dates to be determined.  
    *Contact: 800-541-4802*
*   **SpecGx LLC**: Most strengths (20 mg, 27 mg, 36 mg, 54 mg) have **Limited Availability**. The 10 mg strength (Methylin ER) is **Unavailable**, with the next release expected in late Q2.  
    *Contact: 800-325-8888*
*   **Trigen Laboratories, LLC**: All strengths (18 mg through 72 mg) have **Limited Availability** and are under allocation to current contracted customers.  
    *Contact: 800-541-4802*
*   **Lannett Company, Inc.**: 18 mg is **Available**; 27 mg, 36 mg, and 54 mg are **Unavailable**.  
    *Contact: 844-834-0530*
*   **Sun Pharmaceutical Industries, Inc.**: All presentations (18 mg, 27 mg, 36 mg, 54 mg) are **Unavailable** as they are currently not marketed.  
    *Contact: 800-818-4555*

# Why There's a Shortage

The FDA reports that the primary reason for this shortage is a shortage of an active ingredient required to manufacture the medication.

# What Patients Should Do

If you are affected by this shortage, please consider the following steps:

1.  **Consult Your Healthcare Provider**: Speak with your doctor regarding your treatment plan. Do not adjust your dosage or switch medications without professional medical guidance.
2.  **Talk to Your Pharmacist**: Pharmacists may have information on which specific manufacturers or strengths are currently in stock at their location.
3.  **Contact Manufacturers**: You may use the contact information provided above to inquire about supply timelines for specific products.

**Disclaimer**: This information is for educational purposes only. Patients should always consult with their healthcare provider or pharmacist regarding medical concerns and treatment options.

# Source

Information provided by the FDA Drug Shortage Database.